We showed that Kv1.3 expression was significantly increased in PBMCs from severe COVID-19 patients raising the possibility that upregulation of Kv1.3 could contribute to the hyperactivity of immune cells and increased production of IFN-γ by CD8+ T cells in severe COVID-19. The gene discussed is KCNA3; the disease is COVID-19.